ArticleCancer causes & control : CCC2026
Delay in breast cancer surgery: evaluating patient, healthcare access, and social vulnerability predictors.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Further assessment of structural and social determinant of health effects on breast cancer care timelines: a qualitative study.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeClinical guidelines recommend initiating breast cancer treatment within 60 days of diagnosis. We examined the extent to which patient characteristics, healthcare access, and social vulnerability are associated with delay in surgical treatment among breast cancer patients in Arkansas.
methodsWe used 2013-2019 data from the linked Arkansas Central Cancer Registry and the Arkansas All-Payer Claims Database (APCD) to identify female patients with breast cancer who received first-line surgical treatment (n = 6,279). Time to surgery (TTS) was defined as the interval between diagnosis and first surgical treatment and dichotomized at 60 days. The American Hospital Association Survey and AHRQ's Social Determinants of Health Database captured hospital- and community-level characteristics of healthcare access. We applied multivariable logistic regression models to assess associations between TTS and predictor variables.
resultsOverall, 12% of patients received surgery after 60 days of diagnosis. Non-Hispanic Black patients had 82% higher odds of surgical delay (adjusted odds ratio [aOR] 1.82; 95% confidence interval [CI] 1.46-2.29) compared to non-Hispanic White patients. Residing in counties with high social vulnerability index scores for housing/transportation (aOR 1.38; 95% CI 1.06-1.81) was associated with greater odds of delay, whereas higher county-level rates of routine doctor visits (aOR 0.89; 95% CI 0.82-0.97) were associated with lower odds of delays.
conclusionDisparities in delay in breast cancer surgery persist across race, healthcare access, and community-level vulnerability. These findings underscore the need for strengthened support services and improved continuity of care among vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.